GlassScriptPhysician profile
Karen E Koe
NPI 1780648709
$5,915.51
in general payments reported to CMS, 2019-2025
41 companies · $830 in 2025
The $830 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $950 · 2020: $640 · 2021: $1,159 · 2022: $784 · 2023: $752 · 2024: $800 · 2025: $830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,115 · Education: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,115.06 |
| Education | $267.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $882.32 | 2019-2025 | |
| Amgen INC. | $480.05 | 2021-2025 | Prolia, Evenity, Prolia |
| Astellas Pharma US INC | $453.09 | 2021-2025 | Veozah |
| Therapeuticsmd, INC. | $390.21 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $303.84 | 2019-2025 | |
| Daiichi Sankyo INC. | $300.44 | 2020-2022 | |
| Novo Nordisk INC | $272.37 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $236.44 | 2019-2025 | |
| Exact Sciences Corporation | $225.90 | 2024-2025 | Cologuard Collection Kit |
| Exeltis, USA INC. | $221.08 | 2019-2025 | Slynd |
| Avion Pharmaceuticals | $212.65 | 2019-2021 | |
| Hologic Sales and Service, LLC | $168.30 | 2019-2024 | Aptima, Thinprep 2000 Processor |
| Coopersurgical, INC. | $164.72 | 2019-2025 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $152.37 | 2023-2025 | Myfembree, Gemtesa |
| Millicent US INC | $143.58 | 2024-2025 | Intrarosa, Femring, Femlyv |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Koe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.